PROVECTUS BIOPHARMACEUTICALS, INC. Cash and Restricted Cash
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Cash and Restricted Cash of $3.11 million as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-03-29
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.11M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $97.23K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2021-12-31 | $3.11M 10-K · filed 2022-03-29 |
| 2020-12-31 | $97.23K 10-K · filed 2022-03-29 |